Table 1:
P Fourteen children (12 in 13 years of age fantile autism full syndrome present, 2 atypical pervasive developmental disorder) between 5 and 13 years of age | ||
---|---|---|
Text | Label | MeSH terms |
- Fourteen | Sample size (full) | |
- children | Age (young) | |
- 12 | Sample Size (partial) | |
- autism | Condition (disease) | Autistic Disorder, Child Development Disorders Pervasive |
- 2 | Sample Size (partial) | |
- 5 and 13 | Age (young) | |
I 20 mg Org 2766 (synthetic analog of ACTH 4–9)/day during 4 weeks, or placebo in a randomly assigned sequence. | ||
Text | Label | MeSH terms |
- 20 mg Org 2766 | Pharmacological | Adrenocorticotropic Hormone, Double-Blind Method, Child Development Disorders Pervasive |
- placebo | Control | Double-Blind Method |
O Drug effects and Aberrant Behavior Checklist ratings | ||
Text | Label | MeSH terms |
- Drug effects | Quality of Intervention | |
- Aberrant Behavior Checklist ratings | Mental (behavior) | Attention, Stereotyped Behavior |